PRTA RSI Chart
Last 7 days
5.7%
Last 30 days
7.4%
Last 90 days
-19.5%
Trailing 12 Months
-69.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 54.9M | 57.6M | 141.0M | 91.4M |
2022 | 163.9M | 127.2M | 90.6M | 53.9M |
2021 | 50.8M | 100.7M | 150.6M | 200.6M |
2020 | 769.0K | 797.0K | 749.0K | 853.0K |
2019 | 914.0K | 802.0K | 752.0K | 814.0K |
2018 | 20.9M | 14.2M | 7.6M | 955.0K |
2017 | 7.7M | 14.3M | 20.9M | 27.5M |
2016 | 1.3M | 1.3M | 1.2M | 1.1M |
2015 | 38.5M | 26.2M | 13.9M | 1.6M |
2014 | 21.0M | 30.9M | 40.9M | 50.9M |
2013 | 2.4M | 1.9M | 1.1M | 11.0M |
2012 | 1.0M | 1.6M | 2.1M | 2.7M |
2011 | 0 | 0 | 0 | 507.0K |
2010 | 0 | 0 | 0 | 1.2M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jan 24, 2024 | walker karin l | sold | -170,000 | 34.00 | -5,000 | chief accounting officer |
Jan 24, 2024 | walker karin l | acquired | 67,650 | 13.53 | 5,000 | chief accounting officer |
Dec 20, 2023 | walker karin l | sold | -185,952 | 37.1903 | -5,000 | chief accounting officer |
Dec 20, 2023 | walker karin l | acquired | 67,650 | 13.53 | 5,000 | chief accounting officer |
Nov 30, 2023 | walker karin l | sold | -170,000 | 34.00 | -5,000 | chief accounting officer |
Nov 30, 2023 | walker karin l | acquired | 67,650 | 13.53 | 5,000 | chief accounting officer |
Oct 25, 2023 | walker karin l | sold | -205,191 | 41.0383 | -5,000 | chief accounting officer |
Oct 25, 2023 | walker karin l | acquired | 67,650 | 13.53 | 5,000 | chief accounting officer |
Oct 11, 2023 | smith brandon s. | acquired | 44,480 | 11.12 | 4,000 | chief operating officer |
Oct 11, 2023 | smith brandon s. | sold | -186,985 | 46.7462 | -4,000 | chief operating officer |
Which funds bought or sold PRTA recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Artal Group S.A. | added | 99.73 | 6,584,690 | 24,803,700 | 0.63% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -70.63 | -5,382,600 | 1,347,390 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -5.31 | -550,333 | 1,001,750 | -% |
May 15, 2024 | Granahan Investment Management, LLC | reduced | -19.95 | -6,888,290 | 8,271,200 | 0.29% |
May 15, 2024 | PRELUDE CAPITAL MANAGEMENT, LLC | sold off | -100 | -312,524 | - | -% |
May 15, 2024 | ALGERT GLOBAL LLC | reduced | -1.84 | -592,000 | 1,198,000 | 0.05% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 69.52 | 782,865 | 5,819,120 | -% |
May 15, 2024 | RBF Capital, LLC | unchanged | - | -524,838 | 1,123,620 | 0.06% |
May 15, 2024 | Royal Bank of Canada | reduced | -44.21 | -223,000 | 135,000 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -7.46 | -4,478,650 | 7,651,130 | -% |
Unveiling Prothena Corp PLC's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Prothena Corp PLC)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Prothena Corp PLC News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -100.0% | - | 316,000 | 84,866,000 | 4,019,000 | 2,169,000 | 49,923,000 | 1,517,000 | 1,312,000 | 1,242,000 | 1,172,000 | 139,174,000 | 60,071,000 | 30,215,500 | 360,000 | 157,000 | 195,000 | 141,000 | 256,000 | 205,000 | 167,000 | 186,000 |
Operating Expenses | 3.5% | 81,578,000 | 78,831,000 | 74,558,000 | 70,523,000 | 58,494,000 | 49,995,000 | 51,849,000 | 44,521,000 | 39,097,000 | 34,264,000 | 29,947,000 | 32,122,000 | 32,269,000 | 30,668,000 | 31,003,000 | 26,927,000 | 24,989,000 | 23,530,000 | 21,177,000 | 18,664,000 | 23,140,000 |
S&GA Expenses | -100.0% | - | 16,940,000 | 16,645,000 | 14,512,000 | 13,738,000 | 13,124,000 | 11,989,000 | 12,952,000 | 11,835,000 | 12,206,000 | 11,955,000 | 11,032,000 | 11,125,000 | 9,908,000 | 9,398,000 | 9,656,000 | 9,741,000 | 8,059,000 | 8,691,000 | 9,081,000 | 9,905,000 |
R&D Expenses | 3.6% | 64,114,000 | 61,891,000 | 57,913,000 | 56,011,000 | 44,756,000 | 36,871,000 | 39,860,000 | 31,569,000 | 27,262,000 | 22,058,000 | 17,992,000 | 21,090,000 | 21,144,000 | 20,760,000 | 21,605,000 | 17,271,000 | 15,248,000 | 15,471,000 | 12,486,000 | 9,583,000 | 13,296,000 |
EBITDA Margin | -18.8% | -1.67 | -1.41 | -0.42 | -2.31 | -2.25 | -2.20 | -1.75 | -0.02 | 0.41 | 0.36 | 0.50 | -0.63 | - | - | - | - | - | - | - | - | - |
Interest Expenses | -11.6% | 7,165,000 | 8,102,000 | 8,522,000 | 7,700,000 | 6,690,000 | 3,744,000 | 1,913,000 | 639,000 | 53,000 | 12,000 | 11,000 | 8,000 | 11,000 | 10,000 | 43,000 | 179,000 | 1,137,000 | 1,569,000 | 2,034,000 | 2,296,000 | 2,304,000 |
Income Taxes | 30.2% | -2,200,000 | -3,150,000 | -3,092,000 | -4,300,000 | -2,912,000 | -2,994,000 | -2,653,000 | -1,300,000 | -1,671,000 | 60,000 | -51,000 | 300,000 | 4,660,000 | 353,000 | -215,000 | -255,000 | -166,000 | -131,000 | 468,000 | -156,000 | 198,000 |
Earnings Before Taxes | -5.4% | -74,440,000 | -70,618,000 | 18,815,000 | -58,901,000 | -49,776,000 | 3,345,000 | -48,417,000 | -42,572,000 | -37,961,000 | -33,096,000 | 109,196,000 | 27,896,000 | -32,075,000 | -30,363,000 | -30,792,000 | -26,537,000 | -23,735,000 | -21,685,000 | -18,980,000 | -15,966,000 | -20,667,000 |
EBT Margin | -15.4% | -2.03 | -1.76 | -0.61 | -2.67 | -2.50 | -2.33 | -1.79 | -0.03 | 0.40 | 0.36 | 0.50 | -0.65 | - | - | - | - | - | - | - | - | - |
Net Income | -7.1% | -72,239,000 | -67,476,000 | 21,907,000 | -54,595,000 | -46,864,000 | 6,349,000 | -45,764,000 | -41,244,000 | -36,290,000 | -33,179,000 | 109,247,000 | 27,642,000 | -36,735,000 | -30,716,000 | -30,577,000 | -26,282,000 | -23,569,000 | -21,554,000 | -19,448,000 | -15,810,000 | -20,865,000 |
Net Income Margin | -17.3% | -1.89 | -1.61 | -0.52 | -2.44 | -2.32 | -2.17 | -1.73 | -0.01 | 0.41 | 0.33 | 0.46 | -0.70 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -43.1% | -73,051,000 | -51,038,000 | 9,517,000 | -44,927,000 | -47,458,000 | -4,976,000 | -31,167,000 | -35,263,000 | -37,415,000 | -22,458,000 | 112,110,000 | 36,619,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -10.5% | 623 | 696 | 747 | 721 | 742 | 758 | 554 | 550 | 581 | 609 | 633 | 436 | 380 | 333 | 356 | 379 | 399 | 419 | 451 | 462 | 460 |
Current Assets | -11.5% | 566 | 639 | 691 | 677 | 700 | 719 | 525 | 521 | 556 | 585 | 608 | 409 | 352 | 299 | 320 | 341 | 360 | 378 | 409 | 419 | 415 |
Cash Equivalents | -11.3% | 549 | 619 | 671 | 659 | 686 | 710 | 496 | 509 | 543 | 579 | 600 | 400 | 343 | 298 | 315 | 334 | 353 | 378 | 390 | 398 | 410 |
Net PPE | -4.3% | 4.00 | 4.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 |
Liabilities | -10.5% | 121 | 135 | 130 | 139 | 134 | 136 | 150 | 142 | 143 | 143 | 142 | 148 | 145 | 149 | 146 | 144 | 144 | 146 | 162 | 159 | 147 |
Current Liabilities | -23.9% | 43.00 | 57.00 | 53.00 | 72.00 | 49.00 | 50.00 | 51.00 | 40.00 | 36.00 | 33.00 | 29.00 | 53.00 | 23.00 | 26.00 | 22.00 | 19.00 | 17.00 | 18.00 | 32.00 | 28.00 | 15.00 |
Shareholder's Equity | -10.5% | 502 | 561 | 617 | 582 | 607 | 622 | 405 | 407 | 439 | 466 | 490 | 288 | 235 | 184 | 210 | 234 | 255 | 273 | 289 | 303 | 312 |
Retained Earnings | -7.4% | -1,052 | -980 | -912 | -934 | -879 | -833 | -839 | -793 | -752 | -716 | -682 | -792 | -819 | -783 | -752 | -721 | -695 | -671 | -650 | -630 | -615 |
Additional Paid-In Capital | 0.9% | 1,554 | 1,541 | 1,529 | 1,516 | 1,487 | 1,455 | 1,244 | 1,200 | 1,191 | 1,182 | 1,173 | 1,080 | 1,054 | 967 | 961 | 956 | 950 | 944 | 939 | 933 | 927 |
Shares Outstanding | 0.1% | 54.00 | 54.00 | 54.00 | 53.00 | 53.00 | 52.00 | 47.00 | 47.00 | 47.00 | 44.00 | 46.00 | 44.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 2,900 | - | - | - | 956 | - | - | - | 1,728 | - | - | - | 319 | - | - | - | 329 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -43.1% | -73,051 | -51,038 | 9,517 | -44,927 | -47,458 | -4,976 | -31,167 | -35,263 | -37,415 | -22,458 | 112,110 | 36,619 | -33,666 | -19,094 | -19,404 | -18,697 | -23,167 | -14,488 | -8,943 | -12,103 | -17,435 |
Share Based Compensation | 11.8% | 12,383 | 11,080 | 10,944 | 10,100 | 8,790 | 7,433 | 7,966 | 8,263 | 7,660 | 6,887 | 6,055 | - | - | 5,068 | 5,583 | 5,687 | - | - | 5,816 | 6,277 | - |
Cashflow From Investing | 93.2% | -103 | -1,512 | -442 | -771 | -48.00 | -151 | -130 | -161 | -22.00 | -319 | -208 | - | -48.00 | -51.00 | -77.00 | -46.00 | -22.00 | -106 | -249 | -69.00 | -123 |
Cashflow From Financing | 73.1% | 836 | 483 | 2,711 | 18,625 | 23,284 | 220,765 | 18,130 | 1,225 | 1,337 | 1,773 | 87,013 | 20,219 | 81,327 | - | 64.00 | - | 151 | 13.00 | - | 210 | 5.00 |
Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenue | $ 50 | $ 2,169 |
Operating expenses: | ||
Research and development | 64,114 | 44,756 |
General and administrative | 17,464 | 13,738 |
Total operating expenses | 81,578 | 58,494 |
Loss from operations | (81,528) | (56,325) |
Other income (expense): | ||
Interest income | 7,165 | 6,690 |
Other expense, net | (77) | (141) |
Total other income, net | 7,088 | 6,549 |
Loss before income taxes | (74,440) | (49,776) |
Benefit from income taxes | (2,201) | (2,912) |
Net loss | $ (72,239) | $ (46,864) |
Basic (in dollars per share) | $ (1.34) | $ (0.89) |
Diluted (in dollars per share) | $ (1.34) | $ (0.89) |
Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) | 53,714 | 52,501 |
Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) | 53,714 | 52,501 |
Collaboration revenue | ||
Total revenue | $ 0 | $ 2,119 |
Revenue from license and intellectual property | ||
Total revenue | $ 50 | $ 50 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 546,512 | $ 618,830 |
Accounts receivable | 0 | 5,159 |
Prepaid expenses and other current assets | 18,004 | 13,941 |
Restricted cash, current | 1,352 | 1,352 |
Total current assets | 565,868 | 639,282 |
Non-current assets: | ||
Property and equipment, net | 3,672 | 3,836 |
Operating lease right-of-use assets | 12,510 | 12,162 |
Deferred tax assets | 36,675 | 33,893 |
Restricted cash, non-current | 860 | 860 |
Other non-current assets | 3,609 | 6,349 |
Total non-current assets | 57,326 | 57,100 |
Total assets | 623,194 | 696,382 |
Current liabilities: | ||
Accounts payable | 14,420 | 25,391 |
Accrued research and development | 17,340 | 14,724 |
Lease liability, current | 2,372 | 1,114 |
Other current liabilities | 9,134 | 15,662 |
Total current liabilities | 43,266 | 56,891 |
Non-current liabilities: | ||
Deferred revenue, non-current | 67,405 | 67,405 |
Lease liability, non-current | 10,124 | 10,721 |
Total non-current liabilities | 77,529 | 78,126 |
Total liabilities | 120,795 | 135,017 |
Commitments and contingencies (Note 6) | ||
Shareholders’ equity: | ||
Euro deferred shares, €22 nominal value: Authorized shares — 10,000 at March 31, 2024 and December 31, 2023. Issued and outstanding shares — none at March 31, 2024 and December 31, 2023 | 0 | 0 |
Ordinary shares, $0.01 par value: Authorized shares — 100,000,000 at March 31, 2024 and December 31, 2023. Issued and outstanding shares — 53,720,455 and 53,682,117 at March 31, 2024 and December 31, 2023, respectively | 537 | 537 |
Additional paid-in capital | 1,554,132 | 1,540,859 |
Accumulated deficit | (1,052,270) | (980,031) |
Total shareholders’ equity | 502,399 | 561,365 |
Total liabilities and shareholders’ equity | $ 623,194 | $ 696,382 |